On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

GlaxoSmithKline (United States)

InstitutionResearch output, impact & collaborations

GlaxoSmithKline (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about GlaxoSmithKline (United States)?

ScholarIQrecord summary

GlaxoSmithKline (United States) is a research organisation in Philadelphia, US. OpenAlex records 15,015 works and 2,994,258 citations for it. 3,890 researchers list it as their most recent affiliation.

How many works does GlaxoSmithKline (United States) have?

ScholarIQindexed works

GlaxoSmithKline (United States) has 15,015 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for GlaxoSmithKline (United States) →

How many citations does GlaxoSmithKline (United States) have?

ScholarIQcitation count

GlaxoSmithKline (United States) has 2,994,258 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for GlaxoSmithKline (United States) →

How many researchers are at GlaxoSmithKline (United States)?

ScholarIQresearcher count

GlaxoSmithKline (United States) has 3,890 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at GlaxoSmithKline (United States)?

ScholarIQavg h-index

GlaxoSmithKline (United States) has an average h-index of 44.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of GlaxoSmithKline (United States)?

ScholarIQror

The ROR for GlaxoSmithKline (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for GlaxoSmithKline (United States)?

ScholarIQopenalex

The OpenAlex for GlaxoSmithKline (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind GlaxoSmithKline (United States)?

ScholarIQtop researchers by citations

Jaegil Kim · Cancer Genomics and Diagnostics

275 works65,785 citations

Axel Hoos · Cancer Immunotherapy and Biomarkers

318 works42,548 citations

David A. Roth · Systemic Lupus Erythematosus Research

284 works26,899 citations

Derek T. O’Hagan · Immunotherapy and Immune Responses

281 works23,995 citations

Judith Absalon · Bacterial Infections and Vaccines

62 works23,209 citations

What are the most-cited papers on GlaxoSmithKline (United States)?

ScholarIQmost cited works

A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

Andrew S. Levey, Juan Bosch, Julia B. Lewis, Tom Greene, Nancy Rogers, David A. Roth, for the Modification of Diet in Renal Disease Study Group*

Annals of Internal Medicine. 199915,156 Citations

Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

Caroline Robert, L. Thomas, Igor Bondarenko, Steven O’Day, Jeffrey S. Weber, Claus Garbe, Célèste Lebbé, Jean‐François Baurain, Alessandro Testori, Jean‐Jacques Grob, Neville Davidson, Jon Richards, Michele Maio, Axel Hauschild, Wilson H. Miller, Pere Gascón, Michal Lotem, Kaan Harmankaya, Ramy Ibrahim, Stephen Francis, Tai‐Tsang Chen, Rachel Humphrey, Axel Hoos, Jedd D. Wolchok

New England Journal of Medicine. 20114,477 CitationsOPEN ACCESS

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B. Santiago, Amit Saxena, Yulia Green, Beulah Ji, C. Kleoudis, Susan W. Burriss, Carly Barnett, David A. Roth

New England Journal of Medicine. 20201,005 CitationsOPEN ACCESS

Sequential Therapies for Proliferative Lupus Nephritis

Gabriel Contreras, Victoriano Pardo, Baudouin Leclercq, Oliver Lenz, Elaine Tozman, Patricia O'Nan, David A. Roth

New England Journal of Medicine. 2004820 Citations

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

Sagar Lonial, Hans C. Lee, Ashraf Badros, Suzanne Trudel, Ajay K. Nooka, Ajai Chari, Al‐Ola Abdallah, Natalie S. Callander, Nikoletta Lendvai, Douglas W. Sborov, Attaya Suvannasankha, Katja Weisel, Lionel Karlin, Edward N. Libby, Bertrand Arnulf, Thierry Façon, Cyrille Hulin, K. Martin Kortüm, Paula Rodríguez‐Otero, Saad Z. Usmani, Parameswaran Hari, Rachid Baz, Hang Quach, Philippe Moreau, Peter M. Voorhees, Ira Gupta, Axel Hoos, Eric Zhi, January Baron, Trisha Piontek, Eric Lewis, Roxanne C. Jewell, Elisha J. Dettman, Rakesh Popat, Simona Degli Esposti, Joanna Opalinska, Paul G. Richardson, Adam D. Cohen

The Lancet Oncology. 2019806 Citations

How much of the research on GlaxoSmithKline (United States) is open access?

ScholarIQopen access share

67%OPEN ACCESS

Gold

Green

17%

Hybrid

17%

Bronze

33%

Closed

33%